Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
2012 · Cell Death and Disease · 353 citations
https://doi.org/10.1038/cddis.2012.181
W
W. Gillies McKenna
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
142
Papers
12.1K
Citations
51
h-index
84
i10-index
W. Gillies McKenna is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Cancer-related Molecular Pathways & Pancreatic and Hepatic Oncology Research. The author has an h-index of 51, co-authored 121 publications.
Papers by this author
worksThe anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
2016 · Nature Communications · 245 citations
https://doi.org/10.1038/ncomms12308
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
2012 · Nature Communications · 171 citations
https://doi.org/10.1038/ncomms1786
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
2011 · British Journal of Cancer · 168 citations
https://doi.org/10.1038/bjc.2011.240
Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
2003 · PubMed · 125 citations
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
2020 · British Journal of Cancer · 72 citations
https://doi.org/10.1038/s41416-020-0956-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat